Latest filing published 27 Jan 2026 for Larimar Therapeutics, Inc..
No signal scores available.
Russell Clayton has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Larimar Therapeutics, Inc. and Windtree Therapeutics Inc. We count 4 filings; the first trade dates from 31 March 2012 and the latest from 26 January 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 27 January 2026 with a share grant in Larimar Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations